The use of psilocybin for therapeutic purposes is rapidly gaining acceptance and recognition among medical professionals and patients alike. For individuals who are seeking alternative treatment options, Health Canada's Special Access Program (SAP) can provide access to psilocybin under certain circumstances.
The SAP allows healthcare practitioners to request access to controlled substances for patients who have serious or life-threatening conditions, and where conventional treatments have been ineffective or have resulted in adverse side effects. Psilocybin is one of the substances that can be requested under the SAP.
To request access to psilocybin through the SAP, a healthcare practitioner must submit a detailed application outlining the patient's medical history, treatment history, and rationale for the use of psilocybin. Once the application is approved, the practitioner can obtain psilocybin from a licensed dealer and administer it to the patient under strict supervision.
At Soulview, we're committed to supporting healthcare practitioners and patients who are exploring the potential benefits of psilocybin for therapeutic purposes. We can provide guidance and support throughout the SAP application process, as well as quality-controlled psilocybin products for use in treatment.
If you're interested in exploring the potential benefits of psilocybin for therapeutic purposes, the SAP may be a viable option. Our team of experts is here to help you navigate the process and ensure that you have access to safe and effective psilocybin products. Together, we can work towards a brighter future of mental health and well-being.
Permit Navigation Services
At Soulview, we're dedicated to supporting companies, patients, and medical professionals who are interested in exploring the potential of psilocybin for therapeutic purposes. We offer a wide range of consulting services to help businesses navigate the complex world of psilocybin production and therapy, including SOPs, intellectual property, equipment, and site preparation.
We understand that navigating the regulatory landscape surrounding psilocybin can be challenging, which is why we're committed to providing support and guidance to ensure that businesses have access to the resources and information they need to succeed.
CDSA S. 56 exemption and Licensed Dealer Permit
For patients seeking access to psilocybin medicines and therapy, we offer consulting services to help guide you through the process of obtaining a CDSA S. 56 exemption or accessing Health Canada's Special Access Program. We can provide access to quality-controlled psilocybin products and help you connect with licensed healthcare practitioners who can administer psilocybin therapy under strict supervision.
For medical professionals seeking access to information, training, and resources related to psilocybin therapy, we offer consulting services to help you stay up-to-date on the latest research, regulatory developments, and best practices in psilocybin-assisted therapy.
At Soulview, we're passionate about advancing the field of psilocybin therapy and unlocking its potential to help people achieve greater mental health and well-being. Contact us today to learn more about our consulting services and how we can help you achieve your goals.
